Left Main Coronary Artery Angioplasty vs. Surgery: A Large Meta-Analysis

Courtesy of Dr. Carlos Fava.

Left Main Coronary Artery Angioplasty vs. SurgeryAround 5% of patients undergoing coronary angiography present severe left main coronary artery (LMCA) lesions. Myocardial revascularization surgery (MRS) is the preferred method for this group, although there is evidence from different randomized trials demonstrating the safety and efficacy of unprotected LMCA angioplasty, with results similar to those obtained through the traditional strategy.

 

This analysis included data from 5 randomized studies (PRECOMBAT, SYNTAX, NOBLE, EXCEL, and a study carried out by Boudriot et al.) and 4594 patients.

 

The primary safety endpoint was defined as a composite of all-cause death, infarction, or stroke, and the secondary endpoint was a composite of all-cause death, infarction, stroke, and repeat revascularization.

 

The characteristics of both patient groups were well-balanced. There was no difference in the primary safety endpoint between strategies (odds ratio [OR]: 0.97; 95% confidence interval [CI]: 0.79-1.17; p = 0.73). In patients with complex coronary anatomy (SYNTAX >22), MRS was safer (OR: 1.64; 95% CI: 1.22-2.20; pinteraction = 0.006).

 

The secondary endpoint favored MRS because of significantly higher rates of repeat revascularization for the angioplasty group (OR: 1.85; 95% CI: 1.53-2.23; p <0.001). No differences were observed upon consideration of each individual component of the primary endpoint.

 

Conclusion

Angioplasty using drug-eluting stents and myocardial revascularization surgery are equally safe methods of revascularization for patients with less complex coronary anatomy and significant unprotected left main coronary artery lesions. However, surgery is associated with lower rates of repeat revascularization.

 

Editorial

This meta-analysis including the most modern randomized studies showed that angioplasty is as effective as surgery in patients with non-complex anatomy as defined by a SYNTAX <22 score.

 

While second-generation DES have been developed and complementary methods are applied during angioplasty (intravascular ultrasound [IVUS] vs. optical coherence tomography [OCT]), a higher need for revascularization continues to be the Achilles’ heel of angioplasty.

 

Courtesy of Dr. Carlos Fava. Buenos Aires Favaloro Foundation, Argentina.

 

Original title: Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Stenosis. A Meta-Analysis of Randomized Trials.

Reference: Nitesh Nerlekar et al. Circ Cardiovasc Interv 2016;9e004729.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...